Sign In
Buy ALKS
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026
Alkermes plc: Collecting The Fruits Of The 2023 Spinoff
09:49am, Tuesday, 09'th Apr 2024
Alkermes' spinoff transaction with Mural Oncology resulted in cost cutting and higher EBITDA margins, with strong 2023 profitability gains expected to continue into 2024. ALKS stock is currently under
— Orexin 2 Receptor Agonist ALKS 2680 Demonstrated Clinically Meaningful and Statistically Significant Improvements from Baseline in Mean Sleep Latency Compared to Placebo at All Doses Tested in Bo
DUBLIN , April 8, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the oral presentation of clinical data at the 2024 Congress of the Schizophrenia International Research Society (SIR
Why Alkermes (ALKS) is Poised to Beat Earnings Estimates Again
01:16pm, Tuesday, 02'nd Apr 2024
Alkermes (ALKS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Wednesday, 20'th Mar 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
3 Reasons Why Alkermes (ALKS) Is a Great Growth Stock
01:46pm, Wednesday, 13'th Mar 2024
Alkermes (ALKS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Alkermes (ALKS) is a Strong Momentum Stock
10:50am, Tuesday, 12'th Mar 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Alkermes (ALKS) is a Strong Growth Stock
10:51am, Friday, 08'th Mar 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Alkermes (ALKS) Outpaced the Stock Market Today
07:16pm, Thursday, 07'th Mar 2024
Alkermes (ALKS) concluded the recent trading session at $29.45, signifying a +1.76% move from its prior day's close.
Alkermes (ALKS) Stock Declines While Market Improves: Some Information for Investors
07:16pm, Thursday, 29'th Feb 2024
In the closing of the recent trading day, Alkermes (ALKS) stood at $29.69, denoting a -0.37% change from the preceding trading day.
Why Alkermes (ALKS) is a Top Momentum Stock for the Long-Term
10:56am, Friday, 23'rd Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024
01:04pm, Wednesday, 21'st Feb 2024
Biotech stocks are often at the forefront of innovation. These are the companies we hear about that are driving breakthroughs in healthcare.
Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term
10:51am, Wednesday, 21'st Feb 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript
03:08pm, Thursday, 15'th Feb 2024
Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript
Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates
02:35pm, Thursday, 15'th Feb 2024
Alkermes' (ALKS) earnings and revenues outpace estimates in the fourth quarter of 2023. Strong growth in proprietary products drives year-over-year revenues.
